Marc de Gasparo - Concepedia

Author

Marc de Gasparo

Also Known As

De Gasparo, M., F. Alba, Felix Vargas, M DEGASPARO, M De Gasparo, M Gasparo, M de Gasparo, M. DE GASPARO, M. De Gasparo, M. Gasparo

250

Publications

12.8K

Citations

H-Index

157

Concepts

All Affiliations

Novartis (Switzerland)Universidad de Jaén Universidad de Granada

About

Marc de Gasparo is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	79	5.7K
2	Health Sciences	12	15	962
3	Social Sciences	9	9	229
4	Public Health	5	5	164
5	Natural Sciences	3	3	135

Marc de Gasparo

124

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Preliminary biochemical characterization of two angiotensin II receptor subtypes Steven Whitebread, Michèle Mele, B. Kamber, Biochemical and Biophysical Research Communications Molecular PharmacologySignal TransductionMolecular PhysiologyPreliminary Biochemical CharacterizationMedicine	1989	778
Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography Giuliano Enzi, Marc de Gasparo, Daniele L. Fiore, American Journal of Clinical Nutrition ObesityMetabolic SyndromeComputed TomographyBody CompositionMedical Imaging	1986	546
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors S P H Alexander, Arthur Christopoulos, Anthony P. Davenport, British Journal of Pharmacology	2021	479
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors S P H Alexander, Arthur Christopoulos, Anthony P. Davenport, British Journal of Pharmacology Drug TargetPeptide ScienceSystem PharmacologySystems PharmacologyMolecular Pharmacology	2023	379
Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. Marc de Gasparo, Urs R. Joss, Hans-Peter Ramjoué, Journal of Pharmacology and Experimental Therapeutics	1987	340
The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase Serge P. Bottari, Isabelle N. King, Serge Reichlin, Biochemical and Biophysical Research Communications Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryG Protein-coupled Receptor	1992	253
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT<sub>1</sub>‐receptor subtype Leoluca Criscione, Marc de Gasparo, Peter Bühlmayer, British Journal of Pharmacology Molecular PharmacologyMolecular PhysiologyNonpeptide AntagonistVascular PharmacologyPhysiology	1993	251
Proposed Update of Angiotensin Receptor Nomenclature Marc de Gasparo, Ahsan Husain, Wayne Alexander, Hypertension HypertensionAngiotensin Receptor NomenclatureMedicineAntihypertensive TherapyVascular Biology	1995	222
Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury Lan Wu, Masaru Iwai, Hironori Nakagami, Circulation	2001	216
Angiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 Cells Liette Laflamme, Marc de Gasparo, Jean‐Marc Gallo, Journal of Biological Chemistry	1996	185

Page 1